RESPIRATORY FAILURE TYPES
Respiratory failure is classified into two primary physiologic types: Type 1 (acute hypoxemic respiratory failure) characterized by impaired oxygenation with PaO₂ <60 mm Hg or SpO₂ <90% on room air, and Type 2 (acute hypercapnic respiratory failure) characterized by ventilatory failure with PaCO₂ >6.1 kPa (>45 mm Hg) with accompanying respiratory acidosis (pH <7.35). 1, 2
Type 1: Acute Hypoxemic Respiratory Failure
This represents failure of oxygenation where the respiratory system cannot maintain adequate arterial oxygen levels despite the lungs' ability to eliminate CO₂.
Key Diagnostic Criteria:
- PaO₂ <60 mm Hg (8.0 kPa) or SpO₂ <90% on room air 2, 3
- PaO₂/FiO₂ ratio ≤300 mm Hg defines the broader spectrum 4
- PaCO₂ is typically normal or low (due to compensatory hyperventilation)
Underlying Mechanisms:
The 2026 ATS guideline structures this around conditions causing impaired oxygenation irrespective of precipitating diagnosis 1. This includes:
- Ventilation-perfusion (V/Q) mismatch
- Right-to-left shunts
- Diffusion impairment
- Alveolar hypoventilation
- Conditions like ARDS, pneumonia, pulmonary edema, and pulmonary embolism 2, 5
Clinical Severity Stratification:
- Mild-moderate: SpO₂ 90-94%, requiring supplemental oxygen
- Severe: PaO₂/FiO₂ ≤200 mm Hg with respiratory rate >25 breaths/minute or clinical signs of respiratory distress 4
Type 2: Acute Hypercapnic Respiratory Failure
This represents failure of ventilation where the respiratory system cannot maintain adequate CO₂ clearance, resulting in respiratory acidosis.
Key Diagnostic Criteria:
- PaCO₂ >6.1 kPa (>45 mm Hg) - any value above this is abnormal 2
- pH <7.35 indicating acute respiratory acidosis 2
- May occur even if oxygen saturation is normal 2
Underlying Mechanisms:
The 2026 ATS guideline defines this as occurring when the respiratory system cannot meet ventilatory demand and maintain adequate CO₂ clearance 1. This reflects:
- Reduced effective alveolar ventilation
- Increased physiologic dead space
- Airflow limitation and dynamic hyperinflation
- Altered respiratory drive
- Respiratory muscle fatigue
- Ventilation-perfusion abnormalities increasing work of breathing 1
Common Etiologies:
- COPD exacerbations (most common cause) 1
- Acute asthma
- Cardiogenic pulmonary edema
- Obesity-related hypoventilation
- Drug-induced hypoventilation
- Neuromuscular disorders impairing ventilatory mechanics 1
Clinical Context:
In a hospital study of 3,524 blood gas samples, 27% showed Type 2 respiratory failure versus only 6% with Type 1, demonstrating that hypercapnia is actually more common than pure hypoxemia in hospitalized patients 2.
Important Clinical Distinctions
Acute vs. Chronic Respiratory Failure:
- Acute: Develops rapidly over hours to days with pH <7.35
- Acute-on-chronic: Acute decompensation in patients with baseline chronic respiratory insufficiency (e.g., COPD patients)
- Chronic: Kidneys retain bicarbonate over days to buffer acidity, potentially normalizing pH despite elevated CO₂ 2
Mixed Respiratory Failure:
Patients can have both hypoxemia AND hypercapnia simultaneously, representing combined Type 1 and Type 2 failure. This is common in severe COPD exacerbations and advanced lung disease 1.
Critical Management Implications
The 2026 ATS guideline emphasizes that treatment approach differs fundamentally between types 1:
- Type 1 (Hypoxemic): Focus on improving oxygenation through supplemental oxygen, HFNC, or NIV/CPAP
- Type 2 (Hypercapnic): NIV is standard of care for COPD with acidosis, demonstrating mortality reduction; HFNC may be considered in mild-moderate hypercapnia 1
Common Pitfall:
Avoid excessive oxygen supplementation in Type 2 respiratory failure, particularly in COPD patients, as this can worsen hypercapnia by reducing hypoxic respiratory drive and worsening V/Q matching. Target SpO₂ 88-92% in these patients rather than normal ranges 2.